---
title: "Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293133843.md"
description: "On July 17, 2026, San Carlos based Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) revealed the approval of granting inducement stock options on July 16, 2026. The options cover a total of 139,930 shares of the company's common stock and have been offered to seventeen fresh, non-executive employees. Iovance focuses on developing innovative polyclonal tumor infiltrating lymphocyte (\"TIL\") therapies for cancer patients."
datetime: "2026-07-19T21:31:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293133843.md)
  - [en](https://longbridge.com/en/news/293133843.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293133843.md)
generator: "portal-rs"
---

# Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

On July 17, 2026, San Carlos based Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) revealed the approval of granting inducement stock options on July 16, 2026. The options cover a total of 139,930 shares of the company's common stock and have been offered to seventeen fresh, non-executive employees. Iovance focuses on developing innovative polyclonal tumor infiltrating lymphocyte ("TIL") therapies for cancer patients.

### Related Stocks

- [IOVA.US](https://longbridge.com/en/quote/IOVA.US.md)

## Related News & Research

- [Is Iovance Biotherapeutics (IOVA) Undervalued On Q2 Earnings And Reaffirmed Guidance?](https://longbridge.com/en/news/295324260.md)
- [Lorusso Boosts Iovance Biotherapeutics Price Target to $10 on Strong Amtagvi Momentum and Operational Upside, Reaffirms Buy Rating](https://longbridge.com/en/news/296875833.md)
- [Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing with Global Health Support](https://longbridge.com/en/news/297564670.md)
- [TScan Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard](https://longbridge.com/en/news/297777499.md)
- [14:48 ETResonant Clinical Solutions adquiere Creapharm Bioservices](https://longbridge.com/en/news/298067518.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**